obesity drug news today october 2025 glp-1 Retatrutide, the next generation of from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced. In The Obesity-Drug Revolution Is Stalling

These medications, once primarily diabetes drugs to manage blood glucose levels, now stand as backbone therapies for complex cardiometabolic conditions

When Do the Results Come

(1 mL syringe = 100 units, where each unit equals 0.01 mL of liquid.) Common syringe sizes include: 0.3 mL (30 units): Smallest size, useful for very precise, small doses

in phase 2, in fresh medium with no APAP present, there was progressive morphological damage, leading ultimately to cell death

Because of this acidity, ammonia (NH 3 ) is converted to ammonium (NH 4 + ) which cannot be absorbed, thus trapping ammonia within the colon and resulting in excretion in feces